Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Medical perfusion process is done by pumping fluids such as drug by the way of blood vessels. Perfusion is known as rate at which blood is delivered to tissues or volumes of blood per unit time per unit tissue mass. During surgeries especially cardiothoracic surgery, perfusion must be maintained otherwise it shows bad impacts on the patient’s body. Perfusion system also helps in oxygenation process.
The North American medical perfusion technology has been seeing lucrative growth for the past few years. Medical perfusion technology market in North America is presently being driven by several driving factors. United States and Canada both are dominating the market in the NA region. Medical perfusion technology markets demand is increasing owing to the growing cases of heart diseases such cardiovascular diseases, cerebrovascular diseases, coronary heart diseases, rheumatic heart diseases and increase in practice of organ transplantation. Likewise, well established healthcare industry, rising investment by key players, and initiatives taken by government to promote healthcare industry are further likely to boost the growth of the market. However, high cost of cell based research may hamper the growth of the market.
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the medical perfusion technology market. In addition, complete analysis of changes on medical perfusion technology market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on North American economies, international trade, business investments, GDP and marketing strategies of key players present in the market. COVID-19 impact on the medical perfusion technology market is moderate owing to the decline in demand as many medical procedures are getting postpones in order to prevent the spread of COVID-19. However some of the companies are likely to involve in drug delivery in COVID-19. Such factors are likely to have an impact on medical perfusion technology market.
North American medical perfusion technology market has studied the segments by technique, organ type, component, and country.
Based on technique, North America medical perfusion technology market is segmented into hypothermic machine perfusion and normothermic machine perfusion. The hypothermic machine perfusion segment is projected to witness high growth during the estimated timeframe as hypothermic machine perfusion maintains the potency of vascular bed and it provides nutrients and low demand oxygen to support reduced energy demand. Resulting demand of hypothermic machine perfusion is growing this is in turn propelling the segment growth. Also, normothermic machine perfusion is expected to dominate the market with highest CAGR during the forecast period.
By organ type medical perfusion market is segmented into heart, lungs, kidney, and liver. Kidney segment is dominating the market. Also heart segment is anticipated to observe lucrative growth opportunities in the coming years. During the epidemiologic transition from rural to industrial in countries such as US and Canada, nutritional deficiencies and infectious diseases made way for degenerative diseases such as cardiovascular diseases, cancer, over weight and diabetes. This is ultimately increases heart failure cases in these countries and making more demand of heart transplantation procedures.
Based on components, North America medical perfusion technology market is segmented into perfusion pumps, oxygenators, heart-lung machines, and monitoring system. Oxygenator is accounted for the largest share of the market by component. To treat the patients of Covid-19 in critical care unit, oxygenators demand has increased which is boosting the growth of the segment.
Country wise, the study is comprised of the key countries such as the United States, Canada and Mexico. The United States held the largest market share of North America market and is likely to dominate the medical perfusion technology market over the estimated time frame. Factors like increasing cardiovascular disease, growing geriatric population, funding provided by governments for research and development purpose, advancements in healthcare industries are likely to impel the growth of the segment. Also increasing cardiovascular surgeries in Canada as well as increasing prevalence of cardiovascular diseases in Mexico City are contributing to the medical perfusion technology market growth.
Major Key players of medical perfusion technology market are Getinge AB, Medtronic, LivaNova PLC, XVIVO Perfusion, Terumo Cardiovascular Systems Corporation, OrganOx Limited, Waters Medical Systems, TransMedics, Organ Recovery Systems, XENIOS AG, Paragonix Technologies, Shanghai Genext Medical Technology, Transplant Biomedicals SL and Dr. Franz Köhler Chemie GMBH among the others.
September 2020: Xvivo announced the agreement to acquire all shares in organ assist. Organ assist primarily focuses on developing machines for liver and kidney perfusion. By this acquisition Xvivo becomes first organ preservation and Evaluation Company in the world.
May 2019: Terumo cardiovascular group and Talis clinical announced commercial release of AGC –perfusion and AGC- remote view system in North America. It enables Terumo to distribute Tali’s clinical ACG- perfusion and ACG-Remote View Systems in cardiac operating rooms and intensive care units.
April 2019: FDA granted approval to Xvivo perfusion for its products Xp’s and Steen solution. This approval means Steen solution and Xp’s are only medical devices products which are consent in the US for Ex-vivo lung perfusion of unacceptable donated lungs at body temperature.
The study analysed several segments and their dominating or leading sub segments in the North America medical perfusion market. Segments such as technique, organ type and country are covered in the study. Dominating technique segment is hypothermic perfusion technology; organ type segment is kidney; component segment is oxygenator. Country wise, the study is comprised of the key countries such as the United States, Canada and Mexico. The study also consists of impact of COVID-19 19 pandemic on the NA medical perfusion technology market. It has hampered the growth of the market. As many surgical processes are postponed to stop the spread of COVID-19 which shows negative impact on the market. Study also covers the major key players of medical perfusion technology.
Why to buy this report
